Gene Expression in Peri-Implant Bone with Severe Bone Loss: A Pilot Study Using Human Biopsies
The Journal of Oral Implantology
|April 6, 2026
Summary
Severe peri-implant bone loss involves active inflammation and tissue degradation, indicated by upregulated genetic markers in bone around failing dental implants. Further research is needed to understand these complex processes.
Area of Science:
- Biomaterials Science
- Immunology
- Oral and Maxillofacial Surgery
Background:
- Peri-implant bone loss is a significant complication of osseointegrated dental implants, potentially leading to implant failure.
- The exact mechanisms driving severe peri-implant bone loss remain unclear, with limited research on molecular markers in affected human tissues.
- Cytokine analysis in human peri-implant bone biopsies with severe bone loss has not been previously published.
Purpose of the Study:
- To compare the expression of genetic markers in human bone biopsies and peri-implant crevicular fluid (PICF) from sites with severe bone loss versus unaffected bone in the same patients.
- To investigate the role of inflammatory and bone resorption markers in the etiology of severe peri-implant bone loss.
- To explore potential differences in gene expression between bone tissue and PICF in affected implant sites.
Main Methods:
- Analysis of gene expression using quantitative polymerase chain reaction (qPCR).
- Collection of peri-implant crevicular fluid (PICF) samples using paper points from nine patients undergoing implant removal.
- Harvesting of bone biopsies from sites adjacent to implants with severe bone loss and from unaffected bone within the same patients.
Main Results:
- Upregulation of proinflammatory markers, bone resorption markers, and tissue degradation markers was observed in bone loss sites compared to unaffected bone.
- Similar trends were noted in PICF samples, although these results require cautious interpretation due to the pilot nature of the study.
- Gene expression findings in implant sites with severe bone loss correlated with the clinical presentation, showing elevated markers of inflammation and resorption.
Conclusions:
- The immune system plays an active role in the inflammation and tissue degradation processes surrounding dental implants with severe bone loss.
- Genetic markers for bone resorption and inflammation are significantly elevated in bone affected by severe peri-implant bone loss.
- Further investigation is warranted to elucidate the specific factors contributing to severe bone loss around dental implants and to validate these findings.


